GPT and metabolic syndrome: Furthermore, in a comprehensive risk factor study conducted among overweight children and adolescents, both ALT and hs-CRP (high-sensitivity C-reactive protein) were employed as screening indicators for assessing the presence of metabolic syndrome and cardiovascular disease risks (Oliveira et al., 2008).